Fixed-Dose Netupitant and Palonosetron for Chronic Nausea in Cancer Patients: A Double-Blind, Placebo Run-in Pilot Randomized Clinical Trial

MLA

Rama Maddi, et al. “Fixed-Dose Netupitant and Palonosetron for Chronic Nausea in Cancer Patients: A Double-Blind, Placebo Run-in Pilot Randomized Clinical Trial.” Journal of Pain and Symptom Management, vol. 62, Aug. 2021, p. 223–232.e1. EBSCOhost, https://doi.org/10.1016/j.jpainsymman.2020.12.023.

APA

Rama Maddi, Veronica Puac, Diane Liu, Milind Javle, Michael J. Overman, Ahmed Kaseb, David Hui, Eduardo Bruera, Sriram Yennurajalingam, Zeena Shelal, & Colleen M. Gallagher. (2021). Fixed-Dose Netupitant and Palonosetron for Chronic Nausea in Cancer Patients: A Double-Blind, Placebo Run-in Pilot Randomized Clinical Trial. Journal of Pain and Symptom Management, 62, 223–232.e1. https://doi.org/10.1016/j.jpainsymman.2020.12.023

Chicago

Rama Maddi, Veronica Puac, Diane Liu, Milind Javle, Michael J. Overman, Ahmed Kaseb, David Hui, et al. 2021. “Fixed-Dose Netupitant and Palonosetron for Chronic Nausea in Cancer Patients: A Double-Blind, Placebo Run-in Pilot Randomized Clinical Trial.” Journal of Pain and Symptom Management 62 (August): 223–232.e1. doi:10.1016/j.jpainsymman.2020.12.023.